D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
TCRT holding history
Alaunos Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TCRT overviewAll 13F holders of TCRTFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −186,601−100.0% | Sold out | Holders |
| Q2 2022 | 186,601 | $231.0K | <0.1% | −920,158−83.1% | Reduced | Holders |
| Q1 2022 | 1,106,759 | $722.0K | <0.1% | +146,276+15.2% | Added | Holders |
| Q4 2021 | 960,483 | $1.05M | <0.1% | +190,286+24.7% | Added | Holders |
| Q3 2021 | 770,197 | $1.40M | <0.1% | +80,582+11.7% | Added | Holders |
| Q2 2021 | 689,615 | $1.82M | <0.1% | −292,614−29.8% | Reduced | Holders |
| Q1 2021 | 982,229 | $3.54M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.